Host: Denise M. Dupras, M.D., Ph.D.

Guest: Saad J. Kenderian, M.B., Ch.B.

Dr. Saad Kenderian discusses the use of CAR-T cell therapy, a groundbreaking treatment that genetically modifies a patient's T-cells to target and destroy cancer cells, particularly in blood cancers like leukemia and lymphoma. He highlights the importance of identifying eligible patients, monitoring treatment response, and applying genomics to guide the future of personalized cancer immunotherapy.

Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts